Equity - Narrative (Details) - USD ($) |
1 Months Ended | ||||
|---|---|---|---|---|---|
May 31, 2026 |
Apr. 30, 2026 |
Feb. 28, 2026 |
Jun. 30, 2026 |
Dec. 31, 2025 |
|
| Subsidiary, Sale of Stock [Line Items] | |||||
| Common stock, value authorized | $ 140,010,000 | $ 140,010,000 | |||
| Common stock, shares authorized (in shares) | 140,010,000 | 140,010,000 | |||
| Common stock, par value per share (in USD per share) | $ 1 | $ 1 | |||
| Long-Term Incentive Plan | |||||
| Subsidiary, Sale of Stock [Line Items] | |||||
| Shares issued (in shares) | 100,000 | ||||
| Exercise price (in USD per share) | $ 6.76 | ||||
| Share Incentive Program | |||||
| Subsidiary, Sale of Stock [Line Items] | |||||
| Shares issued (in shares) | 175,000 | 220,000 | |||
| Exercise price (in USD per share) | $ 6.49 | $ 6.7 | |||
| X | ||||||||||
- Definition Common Stock, Value Authorized No definition available.
|
| X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The maximum number of common shares permitted to be issued by an entity's charter and bylaws. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of shares issued under share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average price at which option holders acquired shares when converting their stock options into shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|